This site is for healthcare professionals and doctors only
At Correvio, we have established an integrated pharmaceutical platform incorporating production, distribution, regulatory, medical, health economics, marketing and sales. This comprises a direct pan-European commercial operation and a network of distributors and partners extending reach to over 50 countries worldwide.
Our business approach is to partner with healthcare professionals to help find the best therapeutic solution for their patients. We constantly monitor relevant trends and developments to assist healthcare professionals in decision making, improve care delivery and ultimately improve patient outcomes. In this context, we measure our success with Aggrastat® (tirofiban HCl)* according to the number of Major Adverse Cardiac Events (MACE) prevented.
We specialize in critical care with a deep understanding of interventional cardiology. Our team offers our customers a thorough knowledge of the science, patient care pathways, networks of care and treatment guidelines that are relevant to the therapeutic area we serve. Our Medical Information Centre (MIC) is available to provide medical information support wherever needed.
* Aggrastat® 50 microgram/ml solution for infusion.
Aggrastat® 250 microgram/ml concentrate for solution for infusion.
Correvio International Sàrl
Rue des Alpes 21
Case Postale 1674
1201 Geneva Switzerland
3 Dickinson Drive, Suite 101
Chadds Ford, PA 19317
EU-Phone : +41 (0) 22 907 79 70
US-Phone : +1 610 833 6050
Information : firstname.lastname@example.org